Head-to-head · WeighScore
Go Vida Plena vs MadeMed
By GLP-1 ScorecardUpdated
Score comparison
MadeMed has the higher recorded score — 80.4/100 to 68.2/100.
MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MadeMed advertises all-dose pricing across 30-, 90- and 360-day purchases, with a consultation-fee conflict to resolve before prepaying.
Before you choose
Before comparing the headline prices, the Go Vida Plena review and the MadeMed review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Go Vida Plena vs Mevo Health and HealthHub vs MadeMed compare each of them with another graded program, and the list of alternatives to Go Vida Plena ranks the programs closest to Go Vida Plena on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Go Vida Plena | MadeMed |
|---|---|---|
| WeighScore | 68.2/100 | 80.4/100 |
| Grade | C | B− |
| Site position | #165 | #35 |
| Semaglutide | Advertised shortest-plan payment $269 injectable or $299 oral; confirm quote | $179 every 30 days; $483/90 days or $1,718/360 days ($143.17 equivalent per 30 days); consultation fees and usable supply require confirmation |
| Tirzepatide | Advertised shortest-plan payment $359 injectable or $349 oral; confirm quote | Injection or sublingual: $249 every 30 days; $672/90 days or $2,390/360 days ($199.17 equivalent per 30 days); final fees and supply unverified |
| Coverage | Confirm treatment availability in your state | Confirm selected treatment/state: sublingual tirzepatide FAQ lists 40 states; current injection-state map unverified |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Publishes separate oral and injectable plan totals
- Policy says plans do not automatically renew
- Advertises nutrition support and clinician follow-up
What to consider
- Unused prepaid time is generally not prorated or refunded
- Selected treatment and charge depend on eligibility and the plan
Site position #35 · B−
Strengths
- Public selectors show full charges for 30-, 90- and 360-day plans across the listed GLP-1 products
- Advertises the same pricing across doses, ongoing clinical messaging and included injection supplies
- Current terms name MDI Medical Group PC and four partner pharmacy brands
- A 30-day purchase is advertised alongside the larger prepaid options
What to consider
- Lowest advertised equivalents require $1,718/$2,390 360-day billing plans; terms reject prorated refunds
- Product pages list $20/$30 consultation fees while How It Works says consultation is included and ineligible payments are refunded in full
- The forty-state claim is specific to sublingual tirzepatide; an injection-state map was not established
- Assigned clinician/pharmacy branch, patient lab costs, final first debit and usable prescription supply remain unresolved
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.